Harmony Biosciences Announces FDA Approval Of WAKIX® (Pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy
Advertisement
WAKIX represents the first and only non-scheduled treatment approved for patients with narcolepsy in the U.S.